257 related articles for article (PubMed ID: 23921283)
21. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up.
Houde S; Filiatrault M; Fournier A; Dubé J; D'Arcy S; Bérubé D; Brousseau Y; Lapierre G; Vanasse M
Pediatr Neurol; 2008 Mar; 38(3):200-6. PubMed ID: 18279756
[TBL] [Abstract][Full Text] [Related]
22. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
Alman BA; Raza SN; Biggar WD
J Bone Joint Surg Am; 2004 Mar; 86(3):519-24. PubMed ID: 14996877
[TBL] [Abstract][Full Text] [Related]
23. Impact of steroids on surgical experiences of patients with duchenne muscular dystrophy.
Dooley JM; Gordon KE; MacSween JM
Pediatr Neurol; 2010 Sep; 43(3):173-6. PubMed ID: 20691938
[TBL] [Abstract][Full Text] [Related]
24. Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center.
Marden JR; Freimark J; Yao Z; Signorovitch J; Tian C; Wong BL
J Comp Eff Res; 2020 Feb; 9(3):177-189. PubMed ID: 31922454
[No Abstract] [Full Text] [Related]
25. Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Wong BL; Rybalsky I; Shellenbarger KC; Tian C; McMahon MA; Rutter MM; Sawnani H; Jefferies JL
J Pediatr; 2017 Mar; 182():296-303.e1. PubMed ID: 28043681
[TBL] [Abstract][Full Text] [Related]
26. Deflazacort dose optimization and safety evaluation in Duchenne muscular dystrophy (DOSE): A randomized, double-blind non-inferiority trial.
Reddy C; Patil AN; Suthar R; Sankhyan N; Sirari T; Kumar A; Bhattacharjee S; Saxena S; Saini AG; Sahu JK
Eur J Paediatr Neurol; 2022 May; 38():77-84. PubMed ID: 35500465
[TBL] [Abstract][Full Text] [Related]
27. Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study.
McDonald CM; Henricson EK; Abresch RT; Duong T; Joyce NC; Hu F; Clemens PR; Hoffman EP; Cnaan A; Gordish-Dressman H;
Lancet; 2018 Feb; 391(10119):451-461. PubMed ID: 29174484
[TBL] [Abstract][Full Text] [Related]
28. Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy.
Wood CL; Cheetham TD; Hollingsworth KG; Guglieri M; Ailins-Sahun Y; Punniyakodi S; Mayhew A; Straub V
BMC Pediatr; 2019 Apr; 19(1):131. PubMed ID: 31023296
[TBL] [Abstract][Full Text] [Related]
29. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up.
Lebel DE; Corston JA; McAdam LC; Biggar WD; Alman BA
J Bone Joint Surg Am; 2013 Jun; 95(12):1057-61. PubMed ID: 23783200
[TBL] [Abstract][Full Text] [Related]
30. Deflazacort (Emflaza) for Duchenne muscular dystrophy.
Med Lett Drugs Ther; 2017 Sep; 59(1529):153-154. PubMed ID: 28880848
[No Abstract] [Full Text] [Related]
31. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy.
Daftary AS; Crisanti M; Kalra M; Wong B; Amin R
Pediatrics; 2007 Feb; 119(2):e320-4. PubMed ID: 17272595
[TBL] [Abstract][Full Text] [Related]
32. Comparing Deflazacort and Prednisone in Duchenne Muscular Dystrophy.
Biggar WD; Skalsky A; McDonald CM
J Neuromuscul Dis; 2022; 9(4):463-476. PubMed ID: 35723111
[TBL] [Abstract][Full Text] [Related]
33. Fractures and Linear Growth in a Nationwide Cohort of Boys With Duchenne Muscular Dystrophy With and Without Glucocorticoid Treatment: Results From the UK NorthStar Database.
Joseph S; Wang C; Bushby K; Guglieri M; Horrocks I; Straub V; Ahmed SF; Wong SC;
JAMA Neurol; 2019 Jun; 76(6):701-709. PubMed ID: 30855644
[TBL] [Abstract][Full Text] [Related]
34. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
Mavrogeni S; Giannakopoulou A; Papavasiliou A; Markousis-Mavrogenis G; Pons R; Karanasios E; Noutsias M; Kolovou G; Papadopoulos G
BMC Cardiovasc Disord; 2017 Jul; 17(1):197. PubMed ID: 28738778
[TBL] [Abstract][Full Text] [Related]
35. A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy.
Bonifati MD; Ruzza G; Bonometto P; Berardinelli A; Gorni K; Orcesi S; Lanzi G; Angelini C
Muscle Nerve; 2000 Sep; 23(9):1344-7. PubMed ID: 10951436
[TBL] [Abstract][Full Text] [Related]
36. Meta-analyses of deflazacort versus prednisone/prednisolone in patients with nonsense mutation Duchenne muscular dystrophy.
Shieh PB; Elfring G; Trifillis P; Santos C; Peltz SW; Parsons JA; Apkon S; Darras BT; Campbell C; McDonald CM; ; ; ;
J Comp Eff Res; 2021 Dec; 10(18):1337-1347. PubMed ID: 34693725
[No Abstract] [Full Text] [Related]
37. Developing standardized corticosteroid treatment for Duchenne muscular dystrophy.
Guglieri M; Bushby K; McDermott MP; Hart KA; Tawil R; Martens WB; Herr BE; McColl E; Wilkinson J; Kirschner J; King WM; Eagle M; Brown MW; Willis T; Hirtz D; Shieh PB; Straub V; Childs AM; Ciafaloni E; Butterfield RJ; Horrocks I; Spinty S; Flanigan KM; Kuntz NL; Baranello G; Roper H; Morrison L; Mah JK; Manzur AY; McDonald CM; Schara U; von der Hagen M; Barohn RJ; Campbell C; Darras BT; Finkel RS; Vita G; Hughes I; Mongini T; Pegoraro E; Wicklund M; Wilichowski E; Bryan Burnette W; Howard JF; McMillan HJ; Thangarajh M; Griggs RC
Contemp Clin Trials; 2017 Jul; 58():34-39. PubMed ID: 28450193
[TBL] [Abstract][Full Text] [Related]
38. Short stature and pubertal delay in Duchenne muscular dystrophy.
Wood CL; Straub V; Guglieri M; Bushby K; Cheetham T
Arch Dis Child; 2016 Jan; 101(1):101-6. PubMed ID: 26141541
[TBL] [Abstract][Full Text] [Related]
39. Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.
Angelini C; Peterle E
Acta Myol; 2012 May; 31(1):9-15. PubMed ID: 22655511
[TBL] [Abstract][Full Text] [Related]
40. Corticosteroid Treatment and Growth Patterns in Ambulatory Males with Duchenne Muscular Dystrophy.
Lamb MM; West NA; Ouyang L; Yang M; Weitzenkamp D; James K; Ciafaloni E; Pandya S; DiGuiseppi C;
J Pediatr; 2016 Jun; 173():207-213.e3. PubMed ID: 27039228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
